Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 05 September 2014 | By Alexander Gaffney, RAC,
US drug regulators have set new production quotas for dozens of controlled substances regulated under the Controlled Substances Act (CSA), establishing the quantities of the drugs which may be produced in 2015.
In a 5 September 2014 Federal Register notice, the US Drug Enforcement Administration (DEA), which is charged with setting the quotas, released a list of dozens of schedule I and II controlled substances which will be subject to production quotas in 2015.
"The 2015 aggregate production quotas and assessment of annual needs represent those quantities of schedule I and II controlled substances and the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine to be manufactured in the US in 2015 to provide for the estimated medical, scientific, research, and industrial needs of the US, lawful export requirements, and the establishment and maintenance of reserve stocks," DEA explains in the notice.
So what's expected to change from current quota levels to 2015 quota levels? Of the 63 schedule II and List I drugs—i.e. those drugs recognized to have acceptable medical uses by DEA—22 will see an increase in their quotas next year. Ten will see a decrease in their allowed production limits.
In particular, several painkiller drugs (or drugs used in the production of painkillers) will be subject to massive increases in their quotas relative to the draft quotas released in July 2014.
The increases, DEA explained, are in response to comments from the public that quota amounts were "insufficient to provide for the estimated medical, scientific, research and industrial needs of the US."
But relative to 2014, the 2015 production quota will see both major increases and decreases.
*No quota set in 2014
The complete list of schedule II and List I drugs may be found below. Class I drugs, including marijuana ("marihuana" in DEA parlance) may be found in the Federal Register listing.
*No quota established in 2014
Tags: DEA, Drug Production Quotas, Drug Diversion, Drug Quotas, CSA, Controlled Substances Act, Painkillers, Schedule I, Schedule II, List I
Regulatory Focus newsletters
All the biggest regulatory news and happenings.